Abstract
Chronic respiratory diseases are one of the leading causes of death and morbidity. Therefore the assessment of regional and global ventilation distribution together with pulmonary perfusion imaging becomes more and more important. To date either radionuclide ventilation scintigraphy or high-resolution computed tomography (HR-CT) are used for ventilation assessment and pulmonary parenchyma analysis. But scintigraphy lacks spatial and temporal resolution while HR-CT applies radiation and lacks functional analysis. Over the last years Magnetic resonance imaging (MRI) of the lung has evolved by using aerosolized contrast agents. MRI offers morphological and functional information and does not apply radiation dose. Approaches to use hyperpolarized gases like Xenon and Helium have been made, but these gases are complex and expensive to produce and use. Lately the use of widely available contrast agents like gadolinium chelates has been investigated. As no special MR hardware is needed and gadolinium is straightforward to apply this new method yields promising results for the future. This review is to give an overview about current developments and methods in Gadolinium-enhanced MR ventilation.
Keywords: Computed tomography, GD-DTPA, ventilation, aerosol distribution, Magnetic resonance imaging
Current Respiratory Medicine Reviews
Title: Current Status of Lung Ventilation Imaging with Magnetic Resonance Ventilation Scanning Using Aerosolized Contrast Agents
Volume: 4 Issue: 1
Author(s): Marco Das, Rolf W. Gunther and Patrick Haage
Affiliation:
Keywords: Computed tomography, GD-DTPA, ventilation, aerosol distribution, Magnetic resonance imaging
Abstract: Chronic respiratory diseases are one of the leading causes of death and morbidity. Therefore the assessment of regional and global ventilation distribution together with pulmonary perfusion imaging becomes more and more important. To date either radionuclide ventilation scintigraphy or high-resolution computed tomography (HR-CT) are used for ventilation assessment and pulmonary parenchyma analysis. But scintigraphy lacks spatial and temporal resolution while HR-CT applies radiation and lacks functional analysis. Over the last years Magnetic resonance imaging (MRI) of the lung has evolved by using aerosolized contrast agents. MRI offers morphological and functional information and does not apply radiation dose. Approaches to use hyperpolarized gases like Xenon and Helium have been made, but these gases are complex and expensive to produce and use. Lately the use of widely available contrast agents like gadolinium chelates has been investigated. As no special MR hardware is needed and gadolinium is straightforward to apply this new method yields promising results for the future. This review is to give an overview about current developments and methods in Gadolinium-enhanced MR ventilation.
Export Options
About this article
Cite this article as:
Das Marco, Gunther W. Rolf and Haage Patrick, Current Status of Lung Ventilation Imaging with Magnetic Resonance Ventilation Scanning Using Aerosolized Contrast Agents, Current Respiratory Medicine Reviews 2008; 4 (1) . https://dx.doi.org/10.2174/157339808783497800
DOI https://dx.doi.org/10.2174/157339808783497800 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial from Editor-in-Chief: Are Implanted Upper Airway Stimulation Devices for the Treatment of Obstructive Sleep Apnea Ready for Primetime?
Current Respiratory Medicine Reviews Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
Current Respiratory Medicine Reviews Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?
Current Vascular Pharmacology Neuronal Nitric Oxide Synthase and Sympathetic Nerve Activity in Neurovascular and Metabolic Systems
Current Neurovascular Research The Haywain: Anti-synthetase Antibodies in Patients with Inflammatory Diseases: Targeting Monocytes or Neutrophils?
Current Medicinal Chemistry Management of Blood Pressure and Heart Rate in Patients with Acute Stroke
Current Pharmaceutical Design Stage A: Can Heart Failure Be Prevented?
Current Cardiology Reviews Cardiovascular-Active Venom Toxins: An Overview
Current Medicinal Chemistry T9-T10 Osteomyelitis, Epidural Abscess and Cord Compression Secondary to <i>Mycobacterium abscessus</i>: A Case Report
Infectious Disorders - Drug Targets Vascular Risk Factors and Neurodegeneration in Ageing Related Dementias: Alzheimer’s Disease and Vascular Dementia
Current Alzheimer Research Synthetic Glucocorticoids: Antenatal Administration and Long-term Implications
Current Pharmaceutical Design Clopidogrel in Secondary Ischemic Stroke Prevention
Recent Patents on Cardiovascular Drug Discovery The Important Role of Potatoes, An Underrated Vegetable Food Crop in Human Health and Nutrition
Current Nutrition & Food Science Clinical Profile of Relaxin, a Possible New Drug for Human Use
Current Drug Safety Pancreastatin, A Regulatory Peptide that Modulates Energy Metabolism
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Repetitive Transient Phosphodiesterase-3 Inhibition Eliminates Non-ischemic Cardiac Remodeling and Failure
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Approaches and Recent Trends in Gene Delivery for Treatment of Atherosclerosis
Recent Patents on Drug Delivery & Formulation Impact of Cardiovascular Factors on Pulse Wave Velocity and Total Vascular Resistance in Different Age Group Patients with Cardiovascular Disorders
Current Aging Science Pulmonary Hypertension: Types and Treatments
Current Cardiology Reviews Gene Therapy Approaches for Cardiovascular Diseases
Current Gene Therapy